Global Regulatory Dissonance: A Case Study of Industry Views on the Development of Drugs for Postmenopausal Osteoporosis. [electronic resource]
Publication details: Therapeutic innovation & regulatory science Mar 2015Description: 269-278 p. digitalISSN:- 2168-4804
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.